dihexa clinical trials humans Sublingual BPC-157 First in human trial |
Description
You might experience a little pinkness in the treatment area that lasts 15 to 30 minutes
ISMP is recognized as the global authority on medication safety and provides independent, multidisciplinary expert review of medication errors
Skin irritation tested, it is safe for sensitive skin
BPC-157 appears in research contexts involving gastric peptide research, tissue-repair models, tendon/ligament pathway studies, inflammatory response research
